Emergence of ST1076 as a dominant high-risk clone carrying blaKPC–2 in carbapenem-resistant Pseudomonas aeruginosa from Deqing, Zhejiang, China: a 5-year genomic epidemiology study
Frontiers in Microbiology · 09.07.2026 · 17
DOI: 10.3389/fmicb.2026.1839819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 09.07.2026. Verfasst von Xiaolan Shou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Deqing People's Hospital (Deqing Campus, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University), Deqi…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major healthcare-associated pathogen with high multidrug resistance and mortality. Regional clonal spread of high-risk lineages carrying carbapenemase genes poses significant challenges for infection control.
Methods
We analyzed 100 non-duplicate CRPA clinical isolates collected from June 2020 to December 2024 in Deqing, Zhejiang Province, China. Antimicrobial susceptibility was determined by automated systems, and molecular characterization was performed via whole-genome sequencing, multilocus sequence typing (MLST), core-genome single nucleotide polymorphism (SNP) phylogeny, resistance and virulence gene profiling, and phylogeographic analysis.
Results
The observed resistance rates were 95% for imipenem and 91% for meropenem. Carbapenemase-producing isolates comprised 44% (44/100), with bla KPC –2 predominating (95.5%, 42/44). MLST identified 44 sequence types, including novel ST5216. ST1076 was the dominant clone (23%, 23/100), followed by ST463 (17%). Among ST1076 isolates, 87.0% carried bla KPC –2 . Core-genome SNP analysis revealed tight clustering of 22/23 ST1076 isolates (4–105 SNPs), suggesting possible prolonged nosocomial transmission centered in the Intensive Care Unit (ICU) since mid-2020. Phylogeographic analysis showed strong clustering with ST1076 strains from Ningbo and Hangzhou, supporting intra-provincial dissemination within Zhejiang. Virulence profiling demonstrated high prevalence of T3SS effectors ( exoT 100%, exoY 97%) and frequent oprD inactivation.
Conclusion
This study reveals the emergence and sustained ICU-associated transmission of bla KPC –2 -harboring ST1076 CRPA as a regionally dominant clone in Zhejiang, China, while preserving high susceptibility to ceftazidime/avibactam (CZA). Enhanced local surveillance and strict infection control measures are urgently needed to prevent further spread of this high-risk lineage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Deqing People's Hospital (Deqing Campus, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University), Deqing, Zhejiang, China.
- Jiaxing Key Laboratory of Clinical Laboratory Diagnostics and Translational Research, Affiliated Hospital of Jiaxing University, Jiaxing, China.
- Department of Clinical Laboratory, Feicheng Hospital of Traditional Chinese Medicine, Taian, Shandong, China.
Zitieren
APA
Shou, X., Li, X., Yang, H., & Zhang, X. (2026). Emergence of ST1076 as a dominant high-risk clone carrying blaKPC–2 in carbapenem-resistant Pseudomonas aeruginosa from Deqing, Zhejiang, China: a 5-year genomic epidemiology study. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1839819
Vancouver
Shou X, Li X, Yang H, Zhang X. Emergence of ST1076 as a dominant high-risk clone carrying blaKPC–2 in carbapenem-resistant Pseudomonas aeruginosa from Deqing, Zhejiang, China: a 5-year genomic epidemiology study. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1839819
BibTeX
@article{Shou2026,
author = {Shou, Xiaolan and Li, Xiangchen and Yang, Hongyin and Zhang, Xiaofan},
title = {Emergence of ST1076 as a dominant high-risk clone carrying blaKPC–2 in carbapenem-resistant Pseudomonas aeruginosa from Deqing, Zhejiang, China: a 5-year genomic epidemiology study},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1839819}
}
EUVIMED